ShailyPen Axiom Max and ShailyPen Neo (GLP-1 pens)

Product Description

ShailyPen Neo and ShailyPen Axiom Max™ are key offerings from our comprehensive range of drug delivery systems. They are designed, engineered and manufactured for patient comfort, medication compliance and in-line with regulatory compliance and performance. 
ShailyPen Neo is an innovative spring driven pen injector, intended for use with 1.5ml and 3ml cartridges.

Shaily Axiom Max is a true pull and push activated fixed dose pen injector; intuitive, reliable and user-friendly. It is non-priming, features a low dose extension, prevents partial dose delivery and has a dose counter that shows remaining doses after every use.

Shaily

  • Country/Region:
    United Kingdom
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Packaging & drug delivery
Specifications

Shaily

  • Country/Region:
    United Kingdom
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Packaging & drug delivery

More Products from Shaily (2)

  • Axiom

    Product Axiom

    Axiom Platform Device - Product DescriptionThe Axiom is a fixed-dose pen injector developed for hormonal therapies such as Teriparatide, PTH, and FSH. It is designed to be non-priming, making it highly convenient for self-administration. With a compact form factor and intuitive operation, Axiom supports pr...
  • Maxim

    Product Maxim

    Maxim Platform Device - Product DescriptionThe Maxim is a reusable/disposable pen injector designed for self-medication in chronic therapies such as insulin and GLP-1. It combines precision dosing, ergonomic design, and regulatory compliance, making it ideal for both patients and pharmaceutical companies.